139 related articles for article (PubMed ID: 5556384)
1. Coenzyme O in Duchenne muscular dystrophy. A preliminary therapeutic trial.
Sövik O; Strömme JH; Folkers K
Acta Paediatr Scand; 1971 Jul; 60(4):428-32. PubMed ID: 5556384
[No Abstract] [Full Text] [Related]
2. [Effects of administration of phosphocreatine on the clinical, biochemical and electromyographic evolution of Duchenne's progressive muscular dystrophy].
Radu H; Keresztes L; Stenzel K
Minerva Med; 1968 Dec; 59(99):5524-9. PubMed ID: 5718841
[No Abstract] [Full Text] [Related]
3. [The treatment of progressive muscular dystrophy with nucleosides and nucleotides. Clinical and serologic findings (aldolase and creatinphosphokinase)].
Ceccarelli A; Leone P; Moretti A
Clin Pediatr (Bologna); 1967 Sep; 49(9):468-75. PubMed ID: 5608288
[No Abstract] [Full Text] [Related]
4. [Serum enzyme activities in the families of patients with progressive muscular dystrophy].
Tani J; Yano I; Masaki H; Fukuyama K; Saeki B
Iryo; 1967 Jul; 21(7):848-53. PubMed ID: 5582480
[No Abstract] [Full Text] [Related]
5. [Muscular dystrophy and its problems].
Ueda K; Ito T; Nakata T; Ohara T; Matsumoto K
Nihon Rinsho; 1968 Sep; 26(9):2184-98. PubMed ID: 5752294
[No Abstract] [Full Text] [Related]
6. Serum enzymes in sex-linked (Duchenne) muscular dystrophy.
Shaw RF; Pearson CM; Chowdhury SR; Dreifuss FE
Arch Neurol; 1967 Feb; 16(2):115-22. PubMed ID: 6018043
[No Abstract] [Full Text] [Related]
7. [Progressive muscular dystrophy: CPK, LDH, ALD (aldolase)--EMG, ECG in patients and their families].
Diotallevi P; Bargilli E; Danni M; Dellantonio R; Tocchini M; Milani-Comparetti M
Boll Soc Ital Biol Sper; 1988 Jun; 64(6):523-30. PubMed ID: 3190905
[No Abstract] [Full Text] [Related]
8. [Enzymatic activity of the serum in the family of a progressive muscular dystrophy patient].
Esaki K; Tokoro T; Yamamoto K; Kato T; Asano B
Iryo; 1969 Oct; 23(10):1306-11. PubMed ID: 5364982
[No Abstract] [Full Text] [Related]
9. Evidence against the existence of a subclinical form of X-linked Duchenne muscular dystrophy.
Emery AE; Spikesman A
J Neurol Sci; 1970 Jun; 10(6):523-33. PubMed ID: 5422556
[No Abstract] [Full Text] [Related]
10. [Serum aldolase and creatine phosphokinase in progressive muscular dystrophy].
Ceccarelli A; Leone P
Clin Pediatr (Bologna); 1967 May; 49(5):237-45. PubMed ID: 6080497
[No Abstract] [Full Text] [Related]
11. [Effect of drug administration on the child with progressive muscular dystrophy].
Nakahara T; Annaka S; Baba T; Kanno M
Iryo; 1969 Oct; 23(10):1319-27. PubMed ID: 5364983
[No Abstract] [Full Text] [Related]
12. [Enzyme diagnosis in progressive muscular dystrophies, especially in the Duchenne type].
Pernice W; Beckmann R; Renner S; Wais U
Klin Padiatr; 1989; 201(3):167-76. PubMed ID: 2739342
[TBL] [Abstract][Full Text] [Related]
13. [Membrane effects of insulin in x-chromosome recessive hereditary progressive muscular dystrophy (Duchenne form)].
Blietz R; Kruchten J; Riedl K; Wagner J
Hoppe Seylers Z Physiol Chem; 1967 Dec; 348(12):1609-15. PubMed ID: 5586908
[No Abstract] [Full Text] [Related]
14. Blood enzymes in Duchene's progressive muscular dystrophy and their correlation with the clinical and histological pictures.
Niebrój-Dobosz I; Jedrzejowska H; Hetnarska L
Acta Med Pol; 1970; 11(4):387-93. PubMed ID: 5493781
[No Abstract] [Full Text] [Related]
15. Inflammatory myopathy with facioscapulohumeral distribution.
Munsat TL; Piper D; Cancilla P; Mednick J
Neurology; 1972 Apr; 22(4):335-47. PubMed ID: 5062826
[No Abstract] [Full Text] [Related]
16. [On Becker's benign muscular dystrophy: study of a family with 10 affected members in 6 generations].
Caruso G; Campanella G
Acta Neurol (Napoli); 1968; 23(4):709-31. PubMed ID: 5747395
[No Abstract] [Full Text] [Related]
17. [Plasmatic enzyme studies in individuals with progressive muscular dystrophy in the course of various therapeutic trials].
Mancini G; Lapi AS; Schwarzenberg TL; Canibus R; Natoli V
Arch Ital Pediatr Pueric; 1968; 26(1):36-46. PubMed ID: 5737311
[No Abstract] [Full Text] [Related]
18. Improved detection of Duchenne muscular dystrophy heterozygotes using discriminant analysis of creatine kinase levels.
Muir WA; Knoke J; Martin A; Vignos P; McErlean A
Am J Med Genet; 1983 Jan; 14(1):125-34. PubMed ID: 6829600
[TBL] [Abstract][Full Text] [Related]
19. Investigation on healthy individuals from families of patients with Duchenne type muscular dystrophy.
Hausmanowa-Petrusewicz I; Prot J; Niebrój-Dobosz I; Emeryk B; Wasowicz B; Slucka C; Hetnarska L; Bendarzewska B; Pucek Z
Pol Med J; 1968; 7(1):228-37. PubMed ID: 5652928
[No Abstract] [Full Text] [Related]
20. [Clinical studies in progressive muscular dystrophy].
Prot J
Neurol Neurochir Pol; 1971; 5(4):473-8. PubMed ID: 5122052
[No Abstract] [Full Text] [Related]
[Next] [New Search]
